• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的心脏转移:一项病例研究揭示PSMA PET/CT的关键作用

Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT.

作者信息

Gandini Annalice, Bauckneht Matteo, Sofia Luca, Tomasello Laura, Fornarini Giuseppe, Zanardi Elisa

机构信息

Medical Oncology 1, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, 16132 Genova, Italy.

出版信息

Diagnostics (Basel). 2023 Aug 23;13(17):2733. doi: 10.3390/diagnostics13172733.

DOI:10.3390/diagnostics13172733
PMID:37685271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10487121/
Abstract

Prostate cancer still represents one of the most frequent cancers and causes of death worldwide, despite the huge therapeutic advances in the last decades. The introduction into clinical practice of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has significantly improved diagnostic capacity, allowing for the identification of lesions previously undetectable. The case we are presenting is about a 90-year-old man affected by metastatic prostate cancer and treated with hormonal therapies. At the second progression, the restaging with PSMA PET/CT pointed out a millimetric cardiac intra-atrial metastasis, on which little/scarce literature data are still available. On one hand, this finding confirms the high sensitivity of this technique, which should be preferred over traditional imaging. On the other hand, it suggests that introducing next-generation imaging into clinical practice may provide novel insights about prostate cancer metastatic spread.

摘要

尽管在过去几十年里治疗取得了巨大进展,但前列腺癌仍是全球最常见的癌症之一和主要死因。前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(PSMA PET/CT)引入临床实践后,显著提高了诊断能力,能够识别先前无法检测到的病变。我们介绍的这个病例是关于一名90岁的男性,他患有转移性前列腺癌并接受了激素治疗。在第二次病情进展时,PSMA PET/CT重新分期发现了一个毫米级的心脏心房内转移灶,目前关于该转移灶的文献数据仍然很少。一方面,这一发现证实了该技术的高敏感性,相较于传统成像技术,它更具优势。另一方面,这表明将新一代成像技术引入临床实践可能会为前列腺癌的转移扩散提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e999/10487121/866efaa0c058/diagnostics-13-02733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e999/10487121/f55fc07aa790/diagnostics-13-02733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e999/10487121/866efaa0c058/diagnostics-13-02733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e999/10487121/f55fc07aa790/diagnostics-13-02733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e999/10487121/866efaa0c058/diagnostics-13-02733-g002.jpg

相似文献

1
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT.前列腺癌的心脏转移:一项病例研究揭示PSMA PET/CT的关键作用
Diagnostics (Basel). 2023 Aug 23;13(17):2733. doi: 10.3390/diagnostics13172733.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
A Prospective Comparison of F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).F-前列腺特异性膜抗原-1007 正电子发射断层扫描计算机断层扫描、全身 1.5T 磁共振成像弥散加权成像与传统成像单光子发射计算机断层扫描/计算机断层扫描在前列腺癌原发远处转移分期(PROSTAGE)中的前瞻性比较
Eur Urol Oncol. 2021 Aug;4(4):635-644. doi: 10.1016/j.euo.2020.06.012. Epub 2020 Jul 13.
4
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.前列腺特异性膜抗原正电子发射断层扫描在新发和生化复发前列腺癌中的应用对转移灶位置的影响及对患者管理的影响:一项关键性综述。
Eur Urol Oncol. 2023 Apr;6(2):128-136. doi: 10.1016/j.euo.2023.01.014. Epub 2023 Feb 16.
5
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
6
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描与挽救性放疗治疗生化复发前列腺癌患者的肿瘤学结局改善相关。
Eur Urol Oncol. 2022 Apr;5(2):146-152. doi: 10.1016/j.euo.2022.01.001. Epub 2022 Jan 22.
7
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.一项前瞻性随机多中心研究,评估镓-68 前列腺特异性膜抗原(PSMA)PET/CT 成像在根治性手术或放疗前对高危前列腺癌分期的影响(proPSMA 研究):临床试验方案。
BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.
8
A Multicenter Prospective Clinical Trial of Gallium PSMA HBED-CC PET-CT Restaging in Biochemically Relapsed Prostate Carcinoma: Oligometastatic Rate and Distribution Compared With Standard Imaging.镓 PSMA HBED-CC PET-CT 在后生化复发前列腺癌中的多中心前瞻性临床研究:与标准成像相比的寡转移率和分布。
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):801-808. doi: 10.1016/j.ijrobp.2019.03.014. Epub 2019 Mar 16.
9
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描与常规成像在初治中高危前列腺癌分期中的比较:一项回顾性单中心研究。
Eur Urol Oncol. 2022 Oct;5(5):544-552. doi: 10.1016/j.euo.2020.08.012. Epub 2020 Sep 18.
10
Comparison of Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis.镓标记的前列腺特异性膜抗原配体正电子发射断层扫描/磁共振成像与正电子发射断层扫描/计算机断层扫描用于前列腺癌原发分期的比较:一项系统评价和荟萃分析
Eur Urol Open Sci. 2021 Sep 28;33:61-71. doi: 10.1016/j.euros.2021.09.006. eCollection 2021 Nov.

引用本文的文献

1
Unexplained Cardiac Uptake on Tc-MDP Bone Scan in a Patient with Prostate Cancer.一名前列腺癌患者Tc-MDP骨扫描中出现不明原因的心脏摄取
Asia Ocean J Nucl Med Biol. 2025;13(2):198-202. doi: 10.22038/aojnmb.2025.85251.1609.
2
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma.前列腺癌的非典型转移:α-甲基酰基辅酶A消旋酶(AMACR)作为前列腺特异性膜抗原阴性前列腺腺癌的潜在分子靶点。
Biomolecules. 2024 Dec 26;15(1):17. doi: 10.3390/biom15010017.
3
Editorial for Special Topics: Imaging-Based Diagnosis for Prostate Cancer-State of the Art.

本文引用的文献

1
PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer.用于前列腺癌成像和放射治疗的PSMA靶向纳米诊疗剂
Pharmaceuticals (Basel). 2023 Feb 17;16(2):315. doi: 10.3390/ph16020315.
2
The diagnostic accuracy of Ga-PSMA PET/CT versus Tc-MDP bone scintigraphy for identifying bone metastases in persons with prostate cancer: A systematic review.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)与锝-亚甲基二膦酸盐骨闪烁显像(Tc-MDP)在前列腺癌患者骨转移诊断中的准确性:一项系统评价。
J Med Imaging Radiat Sci. 2023 Sep;54(3):545-555. doi: 10.1016/j.jmir.2023.04.005. Epub 2023 May 20.
3
Increased 18F-PSMA and 18F-FDG Uptake in Lipomatous Hypertrophy of the Interatrial Septum.
专题社论:基于成像的前列腺癌诊断——最新技术水平
Diagnostics (Basel). 2024 Sep 12;14(18):2016. doi: 10.3390/diagnostics14182016.
房间隔脂肪性肥厚中18F-PSMA和18F-FDG摄取增加。
Clin Nucl Med. 2023 Mar 1;48(3):248-249. doi: 10.1097/RLU.0000000000004551. Epub 2023 Jan 14.
4
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.PSMA PET/CT:前列腺癌成像 2.0 的 EANM 程序指南/ SNMMI 程序标准联合。
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486. doi: 10.1007/s00259-022-06089-w. Epub 2023 Jan 5.
5
Recurrent Prostate Cancer Diagnostics with F-PSMA-1007 PET/CT: A Systematic Review of the Current State.使用F-PSMA-1007 PET/CT诊断复发性前列腺癌:当前状态的系统评价
Diagnostics (Basel). 2022 Dec 15;12(12):3176. doi: 10.3390/diagnostics12123176.
6
Prostate cancer cardiac metastasis detected on serial imaging with [Ga] PSMA-11 PET/CT.通过[镓]PSMA - 11 PET/CT连续成像检测到前列腺癌心脏转移。
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3952-3953. doi: 10.1007/s00259-022-05815-8. Epub 2022 May 11.
7
Benefit-harm ratio of the diagnostic workup in patients with prostate cancer of Gleason score from 9 to 10.Gleason评分为9至10分的前列腺癌患者诊断检查的利弊比
Cancer. 2021 Nov 15;127(22):4310-4311. doi: 10.1002/cncr.33811. Epub 2021 Jul 23.
8
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with F-DCFPyL in Prostate Cancer Patients (OSPREY).前列腺特异性膜抗原 PET/CT 联合 F-DCFPyL 对前列腺癌患者的诊断准确性的 2/3 期前瞻性多中心研究(OSPREY)。
J Urol. 2021 Jul;206(1):52-61. doi: 10.1097/JU.0000000000001698. Epub 2021 Feb 26.
9
Diagnostic Performance of F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.F-DCFPyL-PET/CT 在生化复发前列腺癌男性患者中的诊断性能:来自 CONDOR Ⅲ期、多中心研究的结果。
Clin Cancer Res. 2021 Jul 1;27(13):3674-3682. doi: 10.1158/1078-0432.CCR-20-4573. Epub 2021 Feb 23.
10
Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial.去势抵抗性前列腺癌的转移导向治疗(MEDCARE):一项非随机 2 期试验。
BMC Cancer. 2020 May 24;20(1):457. doi: 10.1186/s12885-020-06853-x.